| Lixisenatide in patients with type 2 diabetes and acute coronary syndrome MA Pfeffer, B Claggett, R Diaz, K Dickstein, HC Gerstein, LV Køber, ... New England Journal of Medicine 373 (23), 2247-2257, 2015 | 2494 | 2015 |
| Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk MC Amato, C Giordano, M Galia, A Criscimanna, S Vitabile, M Midiri, ... Diabetes care 33 (4), 920-922, 2010 | 1609 | 2010 |
| Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis C Giordano, G Stassi, R De Maria, M Todaro, P Richiusa, G Papoff, ... Science 275 (5302), 960-963, 1997 | 816 | 1997 |
| Visceral adiposity index: an indicator of adipose tissue dysfunction MC Amato, C Giordano International journal of endocrinology 2014, 2014 | 377 | 2014 |
| Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population MC Amato, C Giordano, M Pitrone, A Galluzzo Lipids in health and disease 10, 1-8, 2011 | 337 | 2011 |
| Nitric oxide primes pancreatic β cells for Fas-mediated destruction in insulin-dependent diabetes mellitus G Stassi, RD Maria, G Trucco, W Rudert, R Testi, A Galluzzo, C Giordano, ... The Journal of experimental medicine 186 (8), 1193-1200, 1997 | 328 | 1997 |
| Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2 C Törn, PW Mueller, M Schlosser, E Bonifacio, PJ Bingley, ... Diabetologia 51, 846-852, 2008 | 311* | 2008 |
| Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised … P Dandona, C Mathieu, M Phillip, L Hansen, SC Griffen, D Tschöpe, ... The lancet Diabetes & endocrinology 5 (11), 864-876, 2017 | 302 | 2017 |
| BRAF (V600E) mutation and the biology of papillary thyroid cancer F Frasca, C Nucera, G Pellegriti, P Gangemi, M Attard, M Stella, M Loda, ... Endocrine-related cancer 15 (1), 191, 2008 | 293 | 2008 |
| Efficient mitochondrial biogenesis drives incomplete penetrance in Leber’s hereditary optic neuropathy C Giordano, L Iommarini, L Giordano, A Maresca, A Pisano, ML Valentino, ... Brain 137 (2), 335-353, 2014 | 287 | 2014 |
| No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII) P Pozzilli, D Pitocco, N Visalli, MG Cavallo, R Buzzetti, A Crino, S Spera, ... Diabetologia 43, 1000-1004, 2000 | 280 | 2000 |
| Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin … O Vaccaro, M Masulli, A Nicolucci, E Bonora, S Del Prato, AP Maggioni, ... The lancet Diabetes & endocrinology 5 (11), 887-897, 2017 | 274 | 2017 |
| Oestrogens ameliorate mitochondrial dysfunction in Leber’s hereditary optic neuropathy C Giordano, M Montopoli, E Perli, M Orlandi, M Fantin, FN Ross-Cisneros, ... Brain 134 (1), 220-234, 2011 | 269 | 2011 |
| NASH in lean individuals R Younes, E Bugianesi Seminars in liver disease 39 (01), 086-095, 2019 | 229 | 2019 |
| Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: the DEPICT-1 52-week study P Dandona, C Mathieu, M Phillip, L Hansen, D Tschöpe, F Thorén, J Xu, ... Diabetes Care 41 (12), 2552-2559, 2018 | 223 | 2018 |
| Papillary thyroid cancer incidence in the volcanic area of Sicily G Pellegriti, F De Vathaire, C Scollo, M Attard, C Giordano, S Arena, ... JNCI: Journal of the National Cancer Institute 101 (22), 1575-1583, 2009 | 192 | 2009 |
| Visceral adiposity index (VAI) is predictive of an altered adipokine profile in patients with type 2 diabetes MC Amato, G Pizzolanti, V Torregrossa, G Misiano, S Milano, C Giordano PLoS One 9 (3), e91969, 2014 | 176 | 2014 |
| Body composition assessment for the definition of cardiometabolic risk MC Amato, V Guarnotta, C Giordano Journal of endocrinological investigation 36, 537-543, 2013 | 174 | 2013 |
| Visceral adiposity index is associated with significant fibrosis in patients with non‐alcoholic fatty liver disease S Petta, MC Amato, V Di Marco, C Cammà, G Pizzolanti, MR Barcellona, ... Alimentary pharmacology & therapeutics 35 (2), 238-247, 2012 | 167 | 2012 |
| Impact of a Mediterranean dietary pattern and its components on cardiovascular risk factors, glucose control, and body weight in people with type 2 diabetes: a real-life study M Vitale, M Masulli, I Calabrese, AA Rivellese, E Bonora, S Signorini, ... Nutrients 10 (8), 1067, 2018 | 164 | 2018 |
